SANUWAVE Health, Inc. (SNWV) stock
SNWVNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 10/30
$1.70−0.11 (-6.08%)
Close on Nov 17, 2026Market cap $14.62MP/E –Yield –
SANUWAVE Health r&d expenses
Research and development expenses are spending on new products and technology.
SANUWAVE Health's R&D Expenses for the twelve months ending Jun 30, 2026 was $2.24M, up 212.3% year over year. For fiscal 2025 it was $1.35M, up 101.0% from the year before. Over ten years it grew -4.6% a year on average. The highest annual figure on record is $3.88M in fiscal 2010.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.35M | +101.0% |
| FY2024 | Dec 31, 2024 | $673.00K | +16.2% |
| FY2023 | Dec 31, 2023 | $579.00K | +2.1% |
| FY2022 | Dec 31, 2022 | $567.00K | -48.5% |
| FY2021 | Dec 31, 2021 | $1.10M | -11.6% |
| FY2020 | Dec 31, 2020 | $1.25M | +5.4% |
| FY2019 | Dec 31, 2019 | $1.18M | +20.4% |
| FY2018 | Dec 31, 2018 | $981.65K | -24.1% |
| FY2017 | Dec 31, 2017 | $1.29M | +14.5% |
| FY2016 | Dec 31, 2016 | $1.13M | -48.1% |
| FY2015 | Dec 31, 2015 | $2.17M | -27.6% |
| FY2014 | Dec 31, 2014 | $3.00M | +30.7% |
| FY2013 | Dec 31, 2013 | $2.30M | +30.3% |
| FY2012 | Dec 31, 2012 | $1.76M | -35.5% |
| FY2011 | Dec 31, 2011 | $2.73M | -29.6% |
| FY2010 | Dec 31, 2010 | $3.88M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $628.00K | +223.7% |
| Q1 FY2026 | Mar 31, 2026 | $660.00K | +217.3% |
| Q4 FY2025 | Dec 31, 2025 | $606.00K | +293.5% |
| Q3 FY2025 | Sep 30, 2025 | $345.00K | +114.3% |
| Q2 FY2025 | Jun 30, 2025 | $194.00K | -0.5% |
| Q1 FY2025 | Mar 31, 2025 | $208.00K | +27.6% |
| Q4 FY2024 | Dec 31, 2024 | $154.00K | +7.7% |
| Q3 FY2024 | Sep 30, 2024 | $161.00K | -2.4% |
| Q2 FY2024 | Jun 30, 2024 | $195.00K | +40.3% |
| Q1 FY2024 | Mar 31, 2024 | $163.00K | +24.4% |
| Q4 FY2023 | Dec 31, 2023 | $143.00K | +95.9% |
| Q3 FY2023 | Sep 30, 2023 | $165.00K | +5.1% |
| Q2 FY2023 | Jun 30, 2023 | $139.00K | -18.7% |
| Q1 FY2023 | Mar 31, 2023 | $131.00K | -21.1% |
| Q4 FY2022 | Dec 31, 2022 | $73.00K | -59.0% |
| Q3 FY2022 | Sep 30, 2022 | $157.00K | -47.1% |
| Q2 FY2022 | Jun 30, 2022 | $171.00K | -37.1% |
| Q1 FY2022 | Mar 31, 2022 | $166.00K | -53.1% |
| Q4 FY2021 | Dec 31, 2021 | $178.00K | -32.1% |
| Q3 FY2021 | Sep 30, 2021 | $297.00K | -31.3% |
| Q2 FY2021 | Jun 30, 2021 | $272.00K | +2.6% |
| Q1 FY2021 | Mar 31, 2021 | $354.00K | +23.3% |
| Q4 FY2020 | Dec 31, 2020 | $262.00K | -16.6% |
| Q3 FY2020 | Sep 30, 2020 | $432.00K | +44.0% |
| Q2 FY2020 | Jun 30, 2020 | $265.00K | -13.8% |
| Q1 FY2020 | Mar 31, 2020 | $287.00K | +10.0% |
| Q4 FY2019 | Dec 31, 2019 | $314.07K | -3.0% |
| Q3 FY2019 | Sep 30, 2019 | $299.90K | -51.8% |
| Q2 FY2019 | Jun 30, 2019 | $307.27K | -6.5% |
| Q1 FY2019 | Mar 31, 2019 | $261.00K | +9.4% |
| Q4 FY2018 | Dec 31, 2018 | $323.91K | -1.1% |
| Q3 FY2018 | Sep 30, 2018 | $622.15K | +133.2% |
| Q2 FY2018 | Jun 30, 2018 | $328.75K | -24.9% |
| Q1 FY2018 | Mar 31, 2018 | $238.48K | -8.4% |
| Q4 FY2017 | Dec 31, 2017 | $327.45K | +330.6% |
| Q3 FY2017 | Sep 30, 2017 | $266.84K | +0.1% |
| Q2 FY2017 | Jun 30, 2017 | $437.91K | – |
| Q1 FY2017 | Mar 31, 2017 | $260.34K | – |
| Q4 FY2016 | Dec 31, 2016 | $76.05K | – |
| Q3 FY2016 | Sep 30, 2016 | $266.47K | – |
See a number that looks wrong?